Working Group Scope New challenges in regulatory science and drug, biologic, and device development provide new opportunities for recognising and leveraging new or emerging technologies and computational tools or under utilised existing technologies. Initiated at the 2013 PHUSE Annual CSS, the Emerging Trends & Technologies Working Group provides a forum for determining interest in specific computational science topics, tools, technologies, and approaches. This Emerging Trends & Technologies Working Group will be an open, transparent forum for sharing pre-competitive means of applying new technologies and is being challenged with creation of well-defined collaborative projects that will describe, prioritise, assess, and assist advancement of these opportunities. Possible topics include (but are not limited to) semantic web applications, analysis metadata, modeling, simulation, and “The Cloud”. Projects incorporating these topics might include prioritisation, development, and piloting for feasibility and value. |
Resources
Click here to search for all Emerging Trends & Technologies deliverables, past projects are housed under the archived section. |
Andy Richardson: Working Group Lead
A pharmacologist by training, Andy has worked in the pharmaceutical and CRO sectors in both senior management and consultant roles for 30 years. Based in the UK, his principal interests are in the areas of clinical data standards and clinical trial operational efficiency, with particular emphasis on data management, statistical programming, computer systems validation and systems implementation.
He is an active member of PHUSE and Co-leads the Emerging Trends & Technologies Working Group, and has contributed as a team member to many PHUSE projects, including the Key Performance Indicators (KPI), the Real-World Evidence and FHIR projects. He is also a member of the British Pharmacology Society, the ACDM, the RQA, and presents regularly at PHUSE conferences and SDEs.